These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32702305)

  • 1. Nomenclature: thyroid-associated orbitopathy, Graves ophthalmopathy, or thyroid eye disease?
    Ing EB; Madjedi K; Hurwitz JJ; Nijhawan N; Oestreicher J; Torun N
    Can J Ophthalmol; 2021 Feb; 56(1):e22-e24. PubMed ID: 32702305
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves' Orbitopathy.
    George A; Diana T; Längericht J; Kahaly GJ
    Front Endocrinol (Lausanne); 2020; 11():629925. PubMed ID: 33603715
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euthyroid Graves' ophthalmopathy with negative autoantibodies.
    Cakir M
    J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Development of Orbitopathy in Graves Thyroidopathy Patients: The Potential Role of TSI Testing.
    Takakura A; Kirkeby K; Earle K; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):369-72. PubMed ID: 25585304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of Graves' hyperthyroidism and Graves' orbitopathy after fine-needle aspiration biopsy of thyroid nodules.
    Lanzolla G; Marcocci C; Marinò M
    J Endocrinol Invest; 2020 Jul; 43(7):1033-1034. PubMed ID: 32077044
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
    Mourits MP
    Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
    Gopinath B; Wescombe L; Nguyen B; Wall JR
    Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
    Meringolo D; Campi I; Costante G
    Endocrine; 2018 Nov; 62(2):490-491. PubMed ID: 29987702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.
    Plöhn S; Hose M; Schlüter A; Michel L; Diaz-Cano S; Hendgen-Cotta UB; Banga JP; Bechrakis NE; Hansen W; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2019 Sep; 29(9):1286-1301. PubMed ID: 31237525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eagle's syndrome mimicking thyroid-associated orbitopathy.
    Dziedzic M; Sokołowski G; Hubalewska-Dydejczyk A; Trofimiuk-Müldner M
    Endokrynol Pol; 2023; 74(5):536-564. PubMed ID: 37779377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.
    Molnár I; Szombathy Z; Kovács I; Szentmiklósi AJ
    J Clin Immunol; 2007 Mar; 27(2):172-80. PubMed ID: 17243008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.